Zobrazeno 1 - 10
of 76
pro vyhledávání: '"A. L. Elizarova"'
Publikováno v:
Онкогематология, Vol 16, Iss 4 (2021)
The purpose of the review is to highlight the current possibilities for the prevention and treatment of venous thrombotic complications in patients with cancer.The data of 52 scientific sources published in the Russian and foreign press in 1997–202
Externí odkaz:
https://doaj.org/article/5ab919f5a07542d78378efdf409cba86
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 103-106 (2018)
Oncological patients have a high risk of thrombotic complications, which worsen the outcomes of antitumor treatment and is one of the leading causes of death. Low molecular weight heparins are the main drugs for the prevention and treatment of thromb
Externí odkaz:
https://doaj.org/article/c398c9d9d57e43b1be28255c11ef8e83
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 5, Pp 640-646 (2017)
Rationale: Extended resections or extended lobectomies are the most common types of surgical interventions in patients with liver malignancies, and they are associated with serious post-operative complications. Aim: To characterize the role of hemost
Externí odkaz:
https://doaj.org/article/fb9846a658394373bf7ee6fabdf69781
Publikováno v:
Медицинский совет, Vol 0, Iss 4S, Pp 87-93 (2021)
Introduction. Patients with cancer are more likely to develop thromboembolic complications, and the occurrence of thrombosis complicates the course of anticancer treatment and worsens the survival rate of cancer patients. Low molecular weight heparin
Autor:
A. L. Elizarova, O. V. Somonova, E.G. Golovnya, A.V. Cytov, J.A. Nesterova, T.V. Davydova, M.M. Dobrovolskaya, U.A. Kornyushenko, N.N. Borisenko
Publikováno v:
Problems of Biological Medical and Pharmaceutical Chemistry. 23:18-24
Autor:
A. V. Snegovoy, Valentina Nikolaevna Blindar, N. E. Kushlinsky, G N Zubrikhina, T. V. Davydova, O V Somonova, M. M. Dobrovolskaya, A. A. Bobryshev, N. V. Lyubimova, A L Elizarova, I. B. Kononenko, T. Yu. Kharitidi
Publikováno v:
Russian Clinical Laboratory Diagnostics. 64:210-215
A study of the clinical analysis of blood and major metabolites of ferrokinetics in 107 breast cancer patients before treatment was conducted. In 31 (28.9%) patients revealed anemic syndrome (AS). A feature of the AS is pronounced microcytosis, eryth
Autor:
O. V. Somonova, M. M. Dobrovolskaya, A. L. Elizarova, Valentina Nikolaevna Blindar, T. V. Davydova, G N Zubrikhina
Publikováno v:
Russian Clinical Laboratory Diagnostics. 64:277-283
Evaluation of anemic syndrome (AS) was performed in 79 patients with advanced stages of Hodgkin’s lymphoma (LH) at various stages of chemotherapy (CT) according to the EACOPP-14 scheme. Against the background of the treatment, the number of erythro
Publikováno v:
Onkogematologiâ, Vol 16, Iss 4 (2021)
The purpose of the review is to highlight the current possibilities for the prevention and treatment of venous thrombotic complications in patients with cancer.The data of 52 scientific sources published in the Russian and foreign press in 1997–202
Autor:
Tatiana V Davidova, A L Elizarova, Yulia A Nesterova, Valentina Nikolaevna Blindar, Marina B Dobrovolskaya, Ustin A Kornyushenko, O V Somonova, Natalia N Borisenko
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 60-65 (2019)
Aim. To highlight the modern treatment and secondary prevention of recurrent thrombotic complications in patients with cancer. Materials and methods. We studied 40 scientific sources published in the Russian and foreign press in the period of 1997 to